Last reviewed: June 25, 2026
Last updated: June 25, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in prescription weight loss medications, can be injected into multiple body locations beyond the standard abdominal injection site. The FDA-approved injection technique includes the abdomen, thigh, and back of the upper arm as acceptable locations, each offering distinct advantages for patient comfort and absorption consistency.
Approved Semaglutide Injection Sites and Placement Guidelines
Semaglutide injections work effectively in three primary body regions: the subcutaneous tissue of the abdomen, the outer thigh, and the back of the upper arm. Each location has roughly equivalent absorption rates when injected into the fatty layer beneath the skin. The abdomen remains the most commonly used site due to accessibility and consistent absorption patterns documented in clinical trials. However, rotating between sites—particularly using the thigh and upper arm as alternatives—helps prevent lipohypertrophy, a condition where repeated injections in the same spot cause thickened or lumpy tissue buildup.
The upper arm injection site sits above the belly button and offers practical advantages for self-administration. The back of the upper arm provides sufficient subcutaneous tissue depth for most patients and reduces visibility concerns compared to abdominal injections. When choosing the upper arm, pinching the skin to identify the fatty layer ensures the needle reaches the appropriate depth. Thigh injections similarly provide easy access and allow patients to self-administer without needing to expose the abdomen, making them preferred for many individuals in work or social settings.
How to Safely Inject Semaglutide Above the Belly Button
Proper injection technique minimizes discomfort and ensures medication effectiveness. Before injecting into the upper arm or thigh, clean the skin with an alcohol swab and allow it to dry completely—injecting into wet alcohol increases stinging sensations. Pinch a fold of skin and fatty tissue between your thumb and fingers to create a raised area, then insert the needle at a 45 to 90-degree angle depending on needle length and your body composition. Most prefilled pens are designed for subcutaneous injection, meaning the needle should penetrate only the fatty layer, not muscle tissue beneath.
After injection, maintain steady pressure on the pen or syringe for the full injection time—typically three seconds for most semaglutide delivery systems. Releasing pressure prematurely can result in incomplete dose delivery. Allow the needle to remain in place for several seconds after the injection completes to ensure all medication has been deposited. Remove the needle slowly at the same angle used for insertion, then apply light pressure with a clean gauze pad if any bleeding occurs. Do not rub or massage the injection site, as this can accelerate absorption and potentially cause bruising.
Site Rotation Strategies to Prevent Tissue Damage and Optimize Results
Rotating injection sites every week or every two weeks prevents the development of lipohypertrophy and lipoatrophy, conditions that can interfere with medication absorption and create cosmetic concerns. A practical rotation strategy involves designating specific weeks for specific body areas: Week 1 and 2 in the abdomen, Week 3 and 4 in the left thigh, Week 5 and 6 in the right thigh, and Week 7 and 8 in the upper arm. Within each body region, select different spots—for example, varying the injection location within the abdomen by moving one to two inches between injections. This systematic approach ensures no single area receives excessive repeated trauma.
PlexusDx patients receiving compounded semaglutide injections benefit from printed rotation guides provided at treatment initiation. Tracking injection sites using a simple calendar or smartphone reminder reduces the cognitive burden of remembering which location was used most recently. Research shows that consistent site rotation correlates with more stable medication levels and fewer injection-site reactions. Patients who rotate sites also report fewer instances of bruising, numbness, or hardened tissue that can occasionally discourage consistent medication adherence.
Safety Considerations and When to Seek Medical Guidance
Certain injection sites require caution or may be inappropriate for specific patients. Individuals with significant scarring, active infections, moles, or tattoos in potential injection areas should avoid those locations and consult with their PlexusDx healthcare provider about alternative sites. Patients with limited subcutaneous tissue—those with very low body fat percentages—may find upper arm or thigh injections challenging due to insufficient fatty layer depth. In these cases, abdominal injection typically remains the most reliable option, though consultation with a clinician can identify whether adjusted needle selection or technique modifications are appropriate.
Minor injection site reactions including redness, itching, or small bruises are normal and typically resolve within 24 to 48 hours. However, persistent swelling lasting more than one week, signs of infection such as warmth or discharge, or allergic reactions including widespread rash require immediate medical attention. PlexusDx provides patient support channels for injection technique questions and adverse event reporting. Patients experiencing unexpected reactions should photograph the affected area and contact their provider within 24 hours to determine whether continued use of that site is safe or whether alternative locations should be prioritized.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I inject semaglutide into my upper arm every week without rotating sites?
Injecting into the same upper arm location repeatedly increases the risk of lipohypertrophy—thickened, bumpy tissue that can interfere with future injections and medication absorption. PlexusDx recommends rotating between the abdomen, both thighs, and upper arm on a weekly or bi-weekly schedule to maintain consistent absorption and prevent tissue damage.
What is the difference between injecting into the upper arm versus the thigh for semaglutide?
Both the upper arm and thigh offer similar absorption rates and are equally effective for semaglutide delivery. The upper arm may feel less visible in social settings, while the thigh is often easier for some patients to access during self-injection. Neither site is superior; the choice depends on individual comfort and convenience preferences.
How much does compounded semaglutide cost at PlexusDx?
PlexusDx compounded semaglutide injections start at $149 per month with no insurance required, no membership fees, and HSA/FSA eligibility. Your dose may need to go up. Your price won't. All medications come from licensed 503A compounding pharmacies and serve all 50 states.
What should I do if I develop bruising or hardened tissue at an injection site?
Minor bruising resolves naturally within 24 to 48 hours and is a normal response to injection. Hardened or thickened tissue suggests lipohypertrophy; discontinue injections in that area immediately and rotate to a different site. If hardness persists beyond two weeks or is accompanied by pain, contact PlexusDx or your healthcare provider for evaluation.
Does the PlexusDx Precision Peptide Genetic Test help determine ideal injection sites?
The Precision Peptide Genetic Test ($99 add-on after first month) identifies genetic variants affecting GLP-1 and GIPR pathway sensitivity, helping personalize your semaglutide dose and compound selection—not injection site selection. However, understanding your genetic response can help optimize overall medication effectiveness across any approved injection location.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Help Ozempic Stomach Pain and Manage Side Effects
Navigating Your Journey: How an Ozempic Pen Works for Effective Weight Management